Press release
Huge Growth Expected in Benign Prostatic Hyperplasia Procedures in Future
According to a report by P&S Intelligence, the benign prostatic hyperplasia (BPH) procedures are predicted to advance at a 2.3% CAGR during 2017–2023.The enlargement of the prostate gland is referred to as BPH. The prostate surrounds the urethra, which is the tube that carries urine from the bladder out of the body. The growth of the prostate gland may squeeze or partly block the urethra, which can cause problems while urinating.Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-procedures/report-sample
Apart from this, the ambulatory surgical centers category is predicted to advance at the fastest pace during the forecast period, as the inflow of BPH patients is rising in these medical settings. The development of technologically innovative procedures is resulting in the rising number of patients in ambulatory surgical centers. Geographically, Europe accounted for the largest number of BPH procedures in the past. The lower cost of BPH treatment in comparison to the U.S., increasing aging population, high healthcare spending are driving the growth of the regional market.
Make an Enquiry before Purchase:https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-procedures/report-sample
A key trend being witnessed in the BPH procedures is the technological advancements in the BPH treatment due to the high number of outpatient procedures. The utilization of minimally invasive procedures, including laser-based treatments, has risen considerably owing to technological advancements in urology. Several treatment methods, including the utilization of pulsed electromagnetic field therapy and Rezum system, are being developed for treating BPH. Dr Allen’s device is one other technologically advanced BPH treatment devices.
Hence, the BPH procedures are being driven by the rising prevalence of BPH and technological advancements in the domain.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Huge Growth Expected in Benign Prostatic Hyperplasia Procedures in Future here
News-ID: 2344138 • Views: …
More Releases from P&S Intelligence

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…

Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…

Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…

Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for BPH
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.…
BPH Surgical Treatment Market worth $17.19 billion in 2030
Browse 368 market data Tables and 59 Figures spread through 328 Pages and in-depth TOC on "BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) - Global Forecast to 2030
The global [https://www.marketsandmarkets.com/Market-Reports/benign-prostatic-hyperplasia-treatment-market-198000374.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=benignprostatichyperplasiasurgicaltreatmentmarket], valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in…
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.…
Benign Prostatic Hyperplasia (BPH) Treatment Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Benign Prostatic Hyperplasia (BPH) Treatment Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The benign prostatic hyperplasia (BPH) treatment market is experiencing significant growth due to the rising prevalence of BPH among the aging male…
How big is Benign Prostate Hyperplasia (BPH) Market?
Benign Prostate Hyperplasia (BPH) Market is forecasted to reach at a CAGR of 6% during the forecast period (2024-2031).
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Benign Prostate Hyperplasia (BPH) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market…
Laser BPH Devices Market Expected to Reach $765.4 Million by 2031
Laser BPH devices market was valued at $460.25 million in 2021, and is estimated to reach $765.4 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031. Prostate enlargement, commonly known as benign prostatic hyperplasia (BPH), is a noncancerous expansion of the prostate gland. Frequent urination, difficulty starting to urinate, a weak stream, the inability to urinate, or a loss of bladder control are examples of symptoms.…